reglab/housing_qa huggingface dataset:
NH Rev Stat § 318-B:1-b (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:1-b - Schedule Tests.

    318-B:1-b Schedule Tests. –||I. Schedule I Tests. The commissioner shall place a substance in schedule I if he finds that the substance:||(a) Has high potential for abuse; and||(b) Has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.||II. Schedule II Tests. The commissioner shall place a substance in schedule II if he finds that:||(a) The substance has high potential for abuse;||(b) The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and||(c) The abuse of the substance may lead to severe psychic or physical dependence.||III. Schedule III Tests. The commissioner shall place a substance in schedule III if he finds that:||(a) The substance has a potential for abuse less than the substances listed in schedules I and II of the current chapter 21, Code of Federal Regulations;||(b) The substance has currently accepted medical use in treatment in the United States; and||(c) Abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.||IV. Schedule IV Tests. The commissioner shall place a substance in schedule IV if he finds that:||(a) The substance has a low potential for abuse relative to substances listed in schedule III of the current chapter 21, Code of Federal Regulations;||(b) The substance has currently accepted medical use in treatment in the United States; and||(c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in schedule III of the current chapter 21, Code of Federal Regulations.||V. Schedule V Tests. The commissioner shall place a substance in schedule V if he finds that:||(a) The substance has a low potential for abuse relative to substances listed in schedule IV of the current chapter 21, Code of Federal Regulations;||(b) The substance has currently accepted medical use in treatment in the United States; and||(c) The substance has limited physical dependence liability or psychological dependence liability relative to the substances in schedule IV of the current chapter 21, Code of Federal Regulations.|||Source. 1985, 293:3. 1995, 310:183, eff. Nov. 1, 1995.|
NH Rev Stat § 318-B:1-c (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:1-c - Flunitrazepam.

[RSA 318-B:1-c contingently repealed by 1998, 359:2; see contingent repeal note set out below.]|    318-B:1-c Flunitrazepam. –||I. The legislature intends that the provisions of paragraph III of this section shall remain in effect until such time as flunitrazepam is scheduled by the commissioner of the department of human services in accordance with and pursuant to RSA 318-B.||II. The legislature finds that flunitrazepam, marketed under the trade name rohypnol, which has a sedative, hypnotic, and amnesiac effect, has no acceptable medical uses in the United States and carries a high potential for abuse. Therefore, flunitrazepam meets the criteria for placement on schedule I of controlled drugs.||III. Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of health and human services, flunitrazepam shall be scheduled as a schedule I controlled drug.|||Source. 1998, 359:1. 2005, 177:138, eff. July 1, 2005.|
NH Rev Stat § 318-B:2-a (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:2-a - Repealed by 1994, 333:34, eff. Jan. 1, 1995.

    318-B:2-a Repealed by 1994, 333:34, eff. Jan. 1, 1995. –|
NH Rev Stat § 318-B:2-b (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:2-b - Counterfeit Drugs; Affirmative Defense.

    318-B:2-b Counterfeit Drugs;  Affirmative Defense. –||It is an affirmative defense to prosecution under RSA 318-B:2, I-a that the actor is:||I. A physician or advanced practice registered nurse who sells, dispenses, or prescribes a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient under his care for a bona fide therapeutic purpose; or||II. A pharmacist who sells or dispenses a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a person at the direction of and upon the written prescription of an attending physician or advanced practice registered nurse, provided any written prescription is properly executed, dated, and signed by the person prescribing on the day when issued and bears the full name and address of the patient for whom the drug is dispensed; or||III. A nurse or intern who, at the explicit direction of and under the supervision of an attending physician, administers a substance which he represents to be or contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient for a bona fide therapeutic purpose; or||IV. An advanced emergency medical care provider who, upon receipt directly or by phone or by radio or by other communication medium of directions to do so from the supervising physician or an emergency/trauma advanced practice registered nurse, administers a substance which he represents to be or to contain a controlled drug, but which in fact neither is nor contains a controlled drug, to a patient for a bona fide therapeutic purpose.|||Source. 1983, 36:2. 1992, 48:7. 1994, 333:20. 2009, 54:5, eff. July 21, 2009.|
NH Rev Stat § 318-B:2-d (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:2-d - Plea by Mail.

    318-B:2-d Plea by Mail. –||I. Any person 18 years of age or older who is charged with a violation of RSA 318-B:2-c, II, III, or IV may enter a plea of guilty, nolo contendere, or not guilty, by mail in a circuit court, district division.||II. Such defendant shall receive, in addition to the summons, a fine notice entitled "Notice of Fine" which shall contain the amount of the fine for a violation of RSA 318-B:2-c, II, III, or IV. A defendant who is issued a summons and notice of fine and who wishes to plead guilty or nolo contendere shall enter his or her plea on the summons and return it with payment of the fine within 30 days of the date of the summons. Payment by credit card may be accepted in lieu of cash payment.||III. If the defendant wishes to enter a plea of not guilty, he or she shall enter such plea on the summons and return it within 30 days of the date of the summons. The circuit court, district division shall schedule a trial.||IV. Whenever a defendant willfully fails to pay a fine in connection with a conviction for a violation of RSA 318-B:2-c, II, III, or IV or payment of such fine cannot be collected, the defendant shall be defaulted and the court may impose an additional fine of $100.|||Source. 2017, 248:2, eff. Sept. 16, 2017.|
NH Rev Stat § 318-B:2-e (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:2-e - Negligent Storage of Marijuana-Infused Products.

    318-B:2-e Negligent Storage of Marijuana-Infused Products. –||I. In addition to any other penalties provided for by law, any person who negligently stores marijuana-infused products, where the negligent storage causes such products to be possessed by a person under 18 years of age, shall be guilty of a misdemeanor. The storing of marijuana-infused products obtained legally in any state in an original childproof container shall be prima facie evidence that a person did not act negligently. Failure to store marijuana-infused products obtained legally in any state in an original childproof container shall be prima facie evidence of negligence.||II. As used in this section, "marijuana-infused products" means products that are comprised of marijuana, marijuana extracts, or resins that have been combined with other ingredients and are intended for use or consumption, including but not limited to, edible products, drinks, ointments, and tinctures.|||Source. 2017, 248:2, eff. Sept. 16, 2017.|
NH Rev Stat § 318-B:3 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:3 - Licensing of Manufacturers and Wholesalers Required.

    318-B:3 Licensing of Manufacturers and Wholesalers Required. –||No person shall manufacture controlled drugs, and no person as a wholesaler shall supply the same, without first having obtained a license to do so as provided in RSA 318:51-a.|||Source. 1969, 421:1. 1973, 198:1. 1985, 324:19. 1990, 129:3, eff. June 18, 1990.|
NH Rev Stat § 318-B:4 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:4 - Repealed by 1985, 324:25, eff. Jan. 1, 1986.

    318-B:4 Repealed by 1985, 324:25, eff. Jan. 1, 1986. –|
NH Rev Stat § 318-B:5 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:5 - Sale by Manufacturer or Wholesaler.

    318-B:5 Sale by Manufacturer or Wholesaler. –||A duly licensed manufacturer or wholesaler may sell and dispense controlled drugs only to any of the following persons, and only on official written orders:||I. To a manufacturer, wholesaler, or pharmacist.||II. To a practitioner.||III. To that person in each hospital designated as in charge of controlled drugs, but only for use by that hospital, pursuant to the restrictions of the board of pharmacy license.||IV. To that person in each laboratory designated as in charge of controlled drugs, but only for use in that laboratory for scientific and medical purposes.||V. To a person in the employ of the United States government or of any state, territorial, district, county, municipal, or insular government purchasing, receiving, possessing, or dispensing controlled drugs by reason of his official duties, upon an exempt official order form as required by the Comprehensive Drug Abuse Prevention and Control Act of 1970, as amended.||VI. To a master of a ship or a person in charge of any aircraft upon which no physician is regularly employed, or to a physician or surgeon, duly licensed in some state, territory, or the District of Columbia to practice his profession, or to a retired commissioned medical officer of the United States Army, Navy, or Public Health Service employed upon such ship or aircraft for the medical needs of persons on board such ship or aircraft, or to a physician, surgeon, or retired commissioned medical officer of the United States Army, Navy, or Public Health Service employed upon such ship or aircraft only in pursuance of a special order form approved by the Attorney General of the United States.||VII. To a person in a foreign country if the provisions of the Comprehensive Drug Abuse Prevention and Control Act of 1970, as amended, are complied with.|||Source. 1969, 421:1. 1977, 547:7, 8. 1983, 292:4, eff. Aug. 17, 1983.|
NH Rev Stat § 318-B:6 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:6 - Possession Lawful.

    318-B:6 Possession Lawful. –||Possession of or control of controlled drugs obtained as authorized shall be lawful if in the regular course of business, occupation, profession, employment, or duty of the possessor. A person who obtains controlled drugs under the provisions of RSA 318-B:5 or otherwise shall not administer, dispense, or otherwise use such drugs within the state, except within the scope of his employment or official duty, and then only for scientific or medical purposes and subject to the provisions of this chapter.|||Source. 1969, 421:1. 1983, 292:5, eff. Aug. 17, 1983.|
NH Rev Stat § 318-B:7 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:7 - Written Orders.

    318-B:7 Written Orders. –||An official written order for any controlled drug in schedule II shall be signed in triplicate by the person giving said order or by his duly authorized agent. The original shall be presented to the person who sells or dispenses the controlled drug or drugs named therein. In the event of the acceptance of such order by said person, each party to the transaction shall preserve his copy of such order for a period of 2 years in such a way as to be readily accessible for inspection by any public officer or employee engaged in the enforcement of this chapter. It shall be deemed compliance with this section if the parties to the transaction have complied with the Comprehensive Drug Abuse Prevention and Control Act of 1970, as amended, or the federal food and drug laws, respecting the requirements governing the use of order forms.|||Source. 1969, 421:1. 1977, 547:9. 1983, 292:6. 1985, 293:4, eff. Aug. 13, 1985.|
NH Rev Stat § 318-B:8 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:8 - Limitation on Use.

    318-B:8 Limitation on Use. –||A person in charge of controlled drugs in a hospital or of a laboratory, or in the employ of this state or of any other state or of any political subdivision thereof, or a master of a ship or a person in charge of any aircraft upon which no physician is regularly employed, or a physician or surgeon duly licensed in some state, territory, or the District of Columbia to practice his profession, or a retired commissioned medical officer of the United States Army, Navy, or Public Health Service employed upon such ship or aircraft who obtains controlled drugs under the provisions of RSA 318-B:5, or otherwise, shall not administer, nor dispense, nor otherwise use such drugs within the state, except within the scope of his employment or official duty, and then only for scientific or medical purposes and subject to the provisions of this chapter.|||Source. 1969, 421:1, eff. Aug. 31, 1969.|
NH Rev Stat § 318-B:11 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:11 - Preparations Exempted.

    318-B:11 Preparations Exempted. –||I. Not Dependence Forming or of Sustaining Character. The department of health and human services may by rule exempt from the application of this chapter, to such extent as it determines to be consistent with the public welfare, pharmaceutical preparations found by the department of health and human services after due notice and hearing:||(a) Either to possess no physiological or psychological dependence forming or sustaining character, or to possess physiological or psychological dependence forming or sustaining character not sufficient to warrant imposition of all the requirements of this chapter, and,||(b) Not to permit recovery of the minute quantity of a controlled drug from the pharmaceutical preparation having such a physiological or psychological dependence forming or sustaining character, with such relative technical chemical separation simplicity and degree of quantitative yield as to create a risk of improper use.||II. Exempt Under Federal Law. In exercising the authority granted in paragraph I, the commissioner of the department of health and human services by rule and without special findings, may grant exempt status to such pharmaceutical preparations as are or may be determined to be exempt under the Comprehensive Drug Abuse Prevention and Control Act of 1970 and regulations and permit the administering, dispensing, or selling of such preparations under the same conditions as permitted by the Comprehensive Drug Abuse Prevention and Control Act of 1970 and regulations and the federal food and drug laws and regulations.||III. Revocation. If the department of health and human services shall find after due notice and a hearing, as required by RSA 318-B:1, VI, that any exempt pharmaceutical preparation does possess a degree of physiological or psychological dependence character that results in material abusive use, it shall by designation publish, once each week for 3 successive weeks, the findings in a newspaper of general circulation in the state. The findings shall be effective, and the exempt status shall cease to apply to such pharmaceutical preparation, 7 days after the date of the publication of the findings. The suspension procedure specified in RSA 318-B:1, VI, shall also apply to such exempt preparation after the hearing date.|||Source. 1969, 421:1. 1977, 547:13. 1985, 190:99, 100. 1995, 310:181, 182, eff. Nov. 1, 1995.|
NH Rev Stat § 318-B:12-a (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:12-a - Treatment for Drug Abuse.

    318-B:12-a Treatment for Drug Abuse. –||Any minor 12 years of age or older may voluntarily submit himself to treatment for drug dependency as defined in RSA 318-B:1, IX, or any problem related to the use of drugs at any municipal health department, state institution or facility, public or private hospital or clinic, any licensed physician or advanced practice registered nurse practicing within such nurse practitioner's specialty, or other accredited state or local social welfare agency, without the consent of a parent, guardian, or any other person charged with the care or custody of said minor. Such parent or legal guardian shall not be liable for the payment for any treatment rendered pursuant to this section. The treating facility, agency or individual shall keep records on the treatment given to minors as provided under this section in the usual and customary manner, but no reports or records or information contained therein shall be discoverable by the state in any criminal prosecution. No such reports or records shall be used for other than rehabilitation, research, or statistical and medical purposes, except upon the written consent of the person examined or treated. Nothing contained herein shall be construed to mean that any minor of sound mind is legally incapable of consenting to medical treatment provided that such minor is of sufficient maturity to understand the nature of such treatment and the consequences thereof.|||Source. 1971, 136:1. 1994, 333:24. 2009, 54:5, eff. July 21, 2009.|
NH Rev Stat § 318-B:13 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:13 - Labels.

    318-B:13 Labels. –||I. Whenever a manufacturer sells or dispenses a controlled drug, and whenever a wholesaler sells or dispenses a controlled drug in a package prepared by him, he shall securely affix to each package in which the drug is contained a label showing in legible English the name and address of the vendor and the quantity, kind, and form of controlled drug contained therein. If any controlled drug is determined by rule of the department of health and human services to be habit forming, the container label shall show clearly the statement "Warning-May be Habit Forming". No person, except a pharmacist for the purpose of filling a prescription under this chapter, shall alter, deface, or remove any label so affixed.||II. Whenever a pharmacist dispenses any controlled drug on prescription issued by a practitioner, he or she shall affix to the container in which such drug is dispensed a label showing the name, address, and registry number of the pharmacy and name or the initials of the pharmacist; the name of the prescribing practitioner; the prescription identification number; the name of the patient; the date dispensed; any directions as may be stated on the prescription; and the name and strength and quantity of the drug dispensed. All drugs dispensed to a patient that have been filled using a centralized prescription processing system shall bear a label containing an identifiable code that provides a complete audit trail of the dispensing of the drug and pharmaceutical care activities. No person shall alter, deface, or remove any label so affixed.||III. Whenever a practitioner other than a pharmacist, but including a physician, dentist, podiatrist, optometrist, veterinarian, or advanced practice registered nurse dispenses a controlled drug, he shall indicate on the container in which such drug is dispensed at least the name of the practitioner; the name and address of the patient, or, in the case of an animal, the name and address of the owner and the species of animal; the date dispensed; the name, strength, and quantity of drug dispensed; and the directions for administering the medication.||IV. A compounded drug product shall also be labeled as provided in RSA 318:14-a.|||Source. 1969, 421:1. 1977, 547:15, 16. 1983, 292:11. 1985, 324:22. 1993, 333:7. 1994, 333:25. 1995, 310:181. 2002, 281:6. 2009, 54:5. 2013, 121:7, eff. Jan. 1, 2014.|
NH Rev Stat § 318-B:14 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:14 - Repealed by 2010, 173:2, eff. Jan. 1, 2011.

    318-B:14 Repealed by 2010, 173:2, eff. Jan. 1, 2011. –|
NH Rev Stat § 318-B:16 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:16 - Common Nuisances.

    318-B:16 Common Nuisances. –||Any store, shop, warehouse, dwellinghouse, building, vehicle, boat, aircraft, or any place whatever which is resorted to by drug-dependent persons for the purpose of using controlled drugs or which is used for the illegal keeping or selling of the same shall be deemed a common nuisance. No person shall knowingly keep or maintain such a common nuisance.|||Source. 1969, 421:1, eff. Aug. 31, 1969.|
NH Rev Stat § 318-B:16-a (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:16-a - Controlled Drugs Containing Opiates; Warning Label Required.

    318-B:16-a Controlled Drugs Containing Opiates;  Warning Label Required. –||Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.|||Source. 2019, 210:1, eff. Jan. 1, 2020.|